Search Results - "TAMINIAU, A"

Refine Results
  1. 1
  2. 2

    Is there still a role for osteoarticular allograft reconstruction in musculoskeletal tumour surgery? a long-term follow-up study of 38 patients and systematic review of the literature by Bus, M P A, van de Sande, M A J, Taminiau, A H M, Dijkstra, P D S

    Published in The bone & joint journal (01-04-2017)
    “…To assess complications and failure mechanisms of osteoarticular allograft reconstructions for primary bone tumours. We retrospectively evaluated 38 patients…”
    Get more information
    Journal Article
  3. 3
  4. 4

    Intercalary Allograft Reconstructions Following Resection of Primary Bone Tumors: A Nationwide Multicenter Study by Bus, M.P.A, Dijkstra, P.D.S, van de Sande, M.A.J, Taminiau, A.H.M, Schreuder, H.W.B, Jutte, P.C, van der Geest, I.C.M, Schaap, G.R, Bramer, J.A.M

    “…BACKGROUND:Favorable reports on the use of massive allografts to reconstruct intercalary defects underline their place in limb-salvage surgery. However, little…”
    Get full text
    Journal Article
  5. 5

    MRI appearances of atypical cartilaginous tumour/grade I chondrosarcoma after treatment by curettage, phenolisation and allografting: recommendations for follow-up by Verdegaal, S H M, van Rijswijk, C S, Brouwers, H F C, Dijkstra, P D S, van de Sande, M A J, Hogendoorn, P C W, Taminiau, A H M

    Published in The bone & joint journal (01-12-2016)
    “…The purpose of this retrospective study was to differentiate between the MRI features of normal post-operative change and those of residual or recurrent…”
    Get more information
    Journal Article
  6. 6

    Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways by Cleton-Jansen, A-M, Anninga, J K, Briaire-de Bruijn, I H, Romeo, S, Oosting, J, Egeler, R M, Gelderblom, H, Taminiau, A H M, Hogendoorn, P C W

    Published in British journal of cancer (01-12-2009)
    “…Background: Osteosarcoma is the most prevalent primary malignant bone tumour in children and young adults, with poor survival in 40% of patients. To identify…”
    Get full text
    Journal Article
  7. 7

    Osteosarcoma over the age of forty by Grimer, R.J, Cannon, S.R, Taminiau, A.M, Bielack, S, Kempf-Bielack, B, Windhager, R, Dominkus, M, Saeter, G, Bauer, H, Meller, I, Szendroi, M, Folleras, G, San-Julian, M, van der Eijken, J

    Published in European journal of cancer (1990) (2003)
    “…The European Musculo Skeletal Oncology Society (EMSOS) has carried out a retrospective review of patients over the age of 40 years with osteosarcoma. 481…”
    Get full text
    Journal Article
  8. 8

    COX-2 expression in chondrosarcoma: A role for celecoxib treatment? by Schrage, Y.M, Machado, I, Meijer, D, Briaire-de Bruijn, I, van den Akker, B.E, Taminiau, A.H.M, Kalinski, T, Llombart-Bosch, A, Bovée, J.V.M.G

    Published in European journal of cancer (1990) (01-02-2010)
    “…Abstract Chondrosarcomas are resistant to conventional chemo- and radiotherapy. A subset of chondrosarcomas arises secondarily in the benign tumour syndromes…”
    Get full text
    Journal Article
  9. 9

    Recommendations for pharmacological clinical trials in children with functional constipation: The Rome foundation pediatric subcommittee on clinical trials by Koppen, I. J. N., Saps, M., Lavigne, J. V., Nurko, S., Taminiau, J. A. J. M., Di Lorenzo, C., Benninga, M. A.

    Published in Neurogastroenterology and motility (01-04-2018)
    “…Background Evidence for the efficacy of commonly used drugs in the treatment of childhood functional constipation (FC) is scarce, studies are often of low…”
    Get full text
    Journal Article
  10. 10

    Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas by Hameetman, L, David, G, Yavas, A, White, SJ, Taminiau, AHM, Cleton-Jansen, A-M, Hogendoorn, PCW, Bovée, JVMG

    Published in The Journal of pathology (01-03-2007)
    “…Mutational inactivation of EXT1 or EXT2 is the cause of hereditary multiple osteochondromas. These genes function in heparan sulphate proteoglycan (HSPG)…”
    Get full text
    Journal Article
  11. 11

    Recommendations for pharmacological clinical trials in children with irritable bowel syndrome: the Rome foundation pediatric subcommittee on clinical trials by Saps, M., Tilburg, M. A. L., Lavigne, J. V., Miranda, A., Benninga, M. A., Taminiau, J. A., Di Lorenzo, C.

    Published in Neurogastroenterology and motility (01-11-2016)
    “…Background There is little published evidence of efficacy for the most commonly used treatments. Thus, there is an urgent need to conduct clinical trials on…”
    Get full text
    Journal Article
  12. 12

    Peripheral chondrosarcoma progression is accompanied by decreased Indian Hedgehog signalling by Hameetman, L, Rozeman, LB, Lombaerts, M, Oosting, J, Taminiau, AHM, Cleton-Jansen, A-M, Bovée, JVMG, Hogendoorn, PCW

    Published in The Journal of pathology (01-08-2006)
    “…Hedgehog (HH) signalling is important for specific developmental processes, and aberrant, increased activity has been described in various tumours. Disturbed…”
    Get full text
    Journal Article
  13. 13

    Review article: the clinical importance of growth in children with inflammatory bowel disease: is it important to the gastroenterologist? by TAMINIAU, J. A.

    Published in Alimentary pharmacology & therapeutics (01-12-2007)
    “…Summary Background  Growth in children with inflammatory bowel disease is often compromised. Aim  To explore the origins of growth retardation in paediatric…”
    Get full text
    Journal Article Conference Proceeding
  14. 14
  15. 15

    Telomere biology in giant cell tumour of bone by Forsyth, RG, De Boeck, G, Bekaert, S, De Meyer, T, Taminiau, AHM, Uyttendaele, D, Roels, H, Praet, MM, Hogendoorn, PCW

    Published in The Journal of pathology (01-04-2008)
    “…Giant cell tumour of bone (GCTB) is a benign bone tumour known for the unpredictable clinical behaviour of recurrences and, in rare instances, distant…”
    Get full text
    Journal Article
  16. 16

    Is Endoscopic Retrograde Cholangiopancreatography Valuable and Safe in Children of All Ages? by Vegting, IL, Tabbers, MM, Taminiau, JAJM, Aronson, DC, Benninga, MA, Rauws, EAJ

    “…ABSTRACT Objective: To evaluate indications, findings, therapies, safety, and technical success of endoscopic retrograde cholangiopancreatography (ERCP) in…”
    Get full text
    Journal Article
  17. 17

    Stress stimulates transepithelial macromolecular uptake in rat jejunum by Kiliaan, A.J. (McMaster University, Hamilton, Ontario, Canada.), Saunders, P.R, Bijlsma, P.B, Berin, M.C, Taminiau, J.A, Groot, J.A, Perdue, M.H

    Published in The American journal of physiology (01-11-1998)
    “…Evidence suggests that stress may be a contributing factor in intestinal inflammatory disease; however, the involved mechanisms have not been elucidated. We…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Clinico-histologic parameters of osteosarcoma patients with late relapse by Hauben, E.I., Bielack, S., Grimer, R., Jundt, G., Reichardt, P., Sydes, M., Taminiau, A.H.M., Hogendoorn, P.C.W.

    Published in European journal of cancer (1990) (01-03-2006)
    “…Primary high-grade intramedullary osteosarcoma of the extremities is a clinically aggressive bone tumour. There is an ongoing effort to further improve…”
    Get full text
    Journal Article